AHR

Q1 2026

Date: 2026-05-08Rank: #97Forward Promise: bullish

American Healthcare REIT (AHR) delivered an exceptionally strong Q1 2026, reporting normalized funds from operations (NFFO) of $0.50 per diluted share, representing 31.6% year-over-year growth. Total portfolio same-store NOI grew 12.1%, marking the ninth consecutive quarter of double-digit growth, driven by robust performance in both the Integrated Senior Health Campuses (ISHC/Trilogy) and Senior Housing Operating Portfolio (SHOP) segments. The company raised its full-year 2026 NFFO per share guidance to a range of $2.09 to $2.30, up $0.04 at the midpoint, reflecting 20% growth over 2025. Year-to-date acquisitions totaled $249.2 million, supplemented by a robust pipeline of over $650 million in awarded deals, funded efficiently via a proactive ATM program and an expanded $800 million credit facility.

Bullishness Score

85.80

μ Mean

91.71

σ Uncertainty

1.97

Forward Promise

8.1

Management Tone

Management exhibited high confidence and deep operational command throughout the call, seamlessly blending strategic vision with granular operational data. The interim leadership structure under Jeffrey Hanson felt entirely stable, with no signs of disruption or uncertainty regarding the CEO's absence. In Q&A, the team was notably relaxed and forthcoming, eagerly providing specific metrics and color to defend their raised guidance.

Confidence: HIGH — Rationale based on highly specific language regarding operational levers (e.g., referral fee reductions, MA contract selection), concrete financial metrics, and a proactive stance on raising guidance despite macroeconomic uncertainties.

Strategic Signals

Management is aggressively executing a capital rotation strategy, selling less strategic outpatient medical and triple-net assets to fund high-growth SHOP acquisitions. This signals a deliberate portfolio repositioning towards higher-margin, demand-driven senior housing and integrated health campuses. The proceeds from these dispositions, combined with retained earnings and ATM proceeds, are being immediately redeployed into a $650 million acquisition pipeline, almost exclusively within the SHOP segment. This strategy accelerates organic growth while maintaining a conservative leverage profile of 3.0x net debt-to-EBITDA.

AHR is leveraging its unique operator-aligned incentive structure, utilizing stock-based compensation to reward operators for outperformance. This approach aligns management, operators, and shareholders, creating a structural competitive advantage in retaining top-tier operators like Trilogy. By granting AHR stock to operators, the company ensures that its partners are incentivized for long-term NOI growth rather than short-term cash flow maximization, deepening the moat around its integrated health campus model.

The company is methodically expanding Trilogy's geographic footprint into Wisconsin via ground-up development, utilizing a highly disciplined, prototype-based approach. Management emphasized that Trilogy's competitive advantage is difficult to replicate due to purpose-built integrated campuses and complex certificate-of-need (CON) navigation. By targeting 3-4 new campuses annually and leveraging a deep pipeline of 30 potential markets, AHR is securing long-term earnings runway in states with high barriers to entry, protecting against future supply overhang.

AHR is utilizing a dynamic revenue and expense management approach, moving beyond simple occupancy growth to optimize bottom-line NOI. Management highlighted specific examples, such as reducing referral fees by over 20% year-over-year, even if it slightly impacts RevPOR, because it ultimately expands margins. This demonstrates a sophisticated, data-driven asset management strategy that prioritizes NOI margin expansion over headline revenue metrics, utilizing proprietary software for daily unit pricing.

Key Metrics

NFFO per Diluted Share$0.5031.6% YoY

Total Portfolio Same-Store NOI Growth12.1%9th consecutive quarter of double-digit growth

Trilogy (ISHC) Same-Store NOI Growth14.5%YoY

SHOP Same-Store NOI Growth19.7%YoY

Trilogy Same-Store Occupancy91.2%Up ~220 bps YoY

SHOP Same-Store Occupancy88.6%Up ~255 bps YoY

Net Debt to Annualized EBITDA3.0xDown from 3.4x at year-end 2025

Year-to-Date Acquisitions$249.2 millionPrimarily SHOP segment

Acquisition Pipeline (Awarded)$650+ millionExpected to close by Q3 2026

Guidance

2026 NFFO per Share: Raised to $2.09 - $2.30 (up $0.04 at midpoint), reflecting 20% growth over 2025

2026 Total Same-Store NOI Growth: Raised to 9% - 12%

2026 Trilogy Same-Store NOI Growth: 11% - 15%

2026 SHOP Same-Store NOI Growth: 15% - 19%

2026 Outpatient Medical Same-Store NOI Growth: 0% - 2%

2026 Triple-Net Lease Same-Store NOI Growth: 2% - 3%

Bottom Line

Price Target: N/A

American Healthcare REIT is executing at an exceptionally high level, demonstrating sustained double-digit organic growth complemented by a robust, de-risked external growth pipeline. The company's operator-first alignment model, particularly with Trilogy, creates a durable competitive moat that insulates the portfolio from regulatory headwinds like CMS rate cuts. Management's proactive capital allocation—funding a $650 million acquisition pipeline through ATM proceeds and asset dispositions while maintaining 3.0x leverage—demonstrates disciplined, accretive growth. With raised 2026 guidance, strong forward visibility, and multiple operational levers (occupancy recovery, rate pushing, margin expansion) still available, AHR offers a highly attractive growth profile relative to its healthcare REIT peers. The slight deceleration in RevPOR and G&A dilution are manageable side effects of a successful scaling strategy.

Forward Promise

Overall: 8.1 · bullish

Highly Confident Execution Amidst Sustained Double-Digit Growth

Management delivered a highly confident, data-rich Q&A, raising guidance and providing specific timelines for their $650M pipeline. Their ability to articulate operational mitigants for macro headwinds signals a durable, scalable growth platform with strong near-term visibility.

Red Flags

Trilogy's Medicare Advantage contract signed in March 2025 provided a substantial, one-time benefit to earnings that will act as a headwind in 2026. While management expressed confidence in counterbalancing this with occupancy and rate growth, the deceleration in underlying Medicare reimbursement rates poses a risk to the sustained double-digit growth narrative if Trilogy cannot continue to selectively renegotiate contracts at premium rates.

The SHOP segment's RevPOR growth decelerated, partly due to the inclusion of non-stabilized assets in the same-store pool. While management framed this as a deliberate 'occupancy first, rate second' strategy, the inclusion of these lower-rate assets masks the true organic pricing power of the stabilized portfolio and could complicate same-store comps in future quarters if rate growth does not accelerate as projected.

Cap rates for senior housing acquisitions have compressed 25 to 50 basis points over the last year, increasing competition for high-quality assets. While management downplayed the impact, noting they still buy below replacement cost, sustained cap rate compression could limit the accretive potential of their $650 million pipeline and pressure long-term returns if the market becomes overheated.

The increase in G&A guidance is entirely driven by rising stock-based compensation, which is a function of the appreciating stock price and new operator incentive grants. While framed positively as alignment, it introduces a non-cash dilution element that could accelerate if the stock continues to appreciate, potentially creating a drag on AFFO/NFFO per share growth if not carefully managed.

Macro Insights

Demographics: The 80+ population is growing at an accelerating rate, driving a structural demand wave for long-term care that is still in its early stages.

Supply Environment: New senior housing supply remains near historic lows because construction costs do not pencil for most developers, creating a favorable operating environment for existing operators.

Regulatory: The preliminary CMS rate increase of 2.4% trails inflation, posing a headwind to skilled nursing facilities that rely heavily on government reimbursement.

Interest Rates: Higher interest rates and construction costs continue to suppress new development, extending the runway for existing assets to achieve outsized occupancy and rate growth.